Inger Persson
Universitetslektor vid Statistiska institutionen
- E-post:
- inger.persson@statistik.uu.se
- Besöksadress:
- Ekonomikum (plan 3)
Kyrkogårdsgatan 10 - Postadress:
- Box 513
751 20 UPPSALA
Ladda ned kontaktuppgifter för Inger Persson vid Statistiska institutionen
Mer information visas för dig som medarbetare om du loggar in.
Biografi
Lektor vid Statistiska institutionen sedan 2012, docent sedan 2022, excellent lärare sedan 2018.
Arbetade dessförinnan med läkemedelsforskning vid bl.a. AstraZeneca.
Medgrundare till forskningsbolaget AlgoDx AB.
https://www.uu.se/en/news/article/?id=17650&typ=artikel&lang=en
https://www.youtube.com/watch?v=NSW-xIS-0Cg
https://sverigesradio.se/artikel/uppsalaforskare-vi-kan-forutse-blodforgiftning
https://www.uu.se/nyheter/arkiv/2023-10-03-inger-persson-far-innovationspriset-hjarnapplet
Publikationer
Senaste publikationer
- Early prediction of sepsis in intensive care patients using the machine learning algorithm NAVOY® Sepsis, a prospective randomized clinical validation study (2024)
- Self‐reported documentation of goals and outcomes of nutrition care (2023)
- A Machine Learning Algorithm Predicting Acute Kidney Injury in Intensive Care Unit Patients (NAVOY Acute Kidney Injury) (2023)
- The Potential Cost and Cost-Effectiveness Impact of Using a Machine Learning Algorithm for Early Detection of Sepsis in Intensive Care Units in Sweden (2022)
- A Machine Learning Sepsis Prediction Algorithm for Intended Intensive Care Unit Use (NAVOY Sepsis) (2021)
Alla publikationer
Artiklar
- Early prediction of sepsis in intensive care patients using the machine learning algorithm NAVOY® Sepsis, a prospective randomized clinical validation study (2024)
- Self‐reported documentation of goals and outcomes of nutrition care (2023)
- A Machine Learning Algorithm Predicting Acute Kidney Injury in Intensive Care Unit Patients (NAVOY Acute Kidney Injury) (2023)
- The Potential Cost and Cost-Effectiveness Impact of Using a Machine Learning Algorithm for Early Detection of Sepsis in Intensive Care Units in Sweden (2022)
- A Machine Learning Sepsis Prediction Algorithm for Intended Intensive Care Unit Use (NAVOY Sepsis) (2021)
- Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy (2020)
- Multivariate two-sample permutation tests for trials with multiple time-to-event outcomes (2019)
- Confirming the Structure of the Survey of Attitudes Toward Statistics (SATS-36) by Swedish Students (2019)
- Adherence to a regulation that aims to prevent and treat malnutrition (2019)
- Reforming Foodservice in Elderly Care (2018)
- Quality indicators of nutritional care practice in elderly care (2017)
- Effect of Farming Practices and Farm History on Incidence of Coconut Lethal Yellowing in Mozambique (2016)
- Safety and efficacy of the combination of pegylated interferon-alpha 2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients (2016)
- EFFECT OF FARMING PRACTICES AND FARM HISTORY ON INCIDENCE OFCOCONUT LETHAL YELLOWING IN MOZAMBIQUE (2016)
- Plasma Proteomics In Chronic Myeloid Leukemia Patients Before And After Initiation Of Tyrosine Kinase Inhibitor Therapy Reveals Induced Th1 Immunity And Loss Of Angiogenic Stimuli (2016)
- Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli (2016)
- Outcome after HSCT in Philadelphia chromosome positive acute lymphoblastic leukemia in Sweden (2014)
- Validation of an Algorithm for Chronic Periodontitis Risk Assessment and Prognostication (2010)
- Validation of an Algorithm for Chronic Periodontitis Risk Assessment and Prognostication (2010)
- A Comparison of Statistical Tests for Proportional Hazards in the Cox Model When Covariates are Measured With Error (2010)
- A Comparison of Statistical Tests for Assessing the Proportional Hazards Assumption in the Cox Model (2008)
- Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126) (2008)
- A Comparison of Graphical Methods for Assessing the Proportional Hazards Assumption in the Cox Model (2007)
- Prevention of Schizophrenia Relapse with Extended Release Quetiapine Fumarate Dosed Once Daily (2007)
- Bias Of The Cox Model Hazard Ratio (2005)
Konferenser
